These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 800400)
21. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells. Gelfand MC; Paul WE J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498 [TBL] [Abstract][Full Text] [Related]
22. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum. Kinnamon KE; Blackwell LH; Ledney GD Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088 [No Abstract] [Full Text] [Related]
23. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier. Koch U; Choksi S; Marcucci L; Korngold R J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252 [TBL] [Abstract][Full Text] [Related]
24. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433 [TBL] [Abstract][Full Text] [Related]
25. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2. Gorczynski RM; Fu XM; Issekutz T; Cohen Z Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338 [TBL] [Abstract][Full Text] [Related]
26. Effect of laser irradiation and immunosuppressive treatment on survival of mouse skin allotransplants. Naményi J; Mester E; Földes I; Tisza S Acta Chir Acad Sci Hung; 1975; 16(4):327-35. PubMed ID: 4941 [TBL] [Abstract][Full Text] [Related]
27. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination. Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353 [TBL] [Abstract][Full Text] [Related]
28. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit. Ponsford FM; Symes MO Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373 [No Abstract] [Full Text] [Related]
29. [Immunosuppressive activity of rabbit anti-mouse thymocyte sera produced with subcellular fractions (author's transl)]. Liabeuf A; Elie R; Lamoureux G Ann Immunol (Paris); 1973 May; 124(2):197-207. PubMed ID: 4583647 [No Abstract] [Full Text] [Related]
30. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation. Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637 [TBL] [Abstract][Full Text] [Related]
31. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice. Margenthaler JA; Landeros K; Kataoka M; Flye MW Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472 [TBL] [Abstract][Full Text] [Related]
33. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement. Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278 [TBL] [Abstract][Full Text] [Related]
34. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse. Lems SP; Jacobs CW; Capel PJ; Koene RA J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896 [TBL] [Abstract][Full Text] [Related]
35. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro. Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277 [TBL] [Abstract][Full Text] [Related]
36. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice. McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830 [TBL] [Abstract][Full Text] [Related]
38. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody. Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173 [TBL] [Abstract][Full Text] [Related]
39. Promotion of fetal liver cell engraftment in irradiated mice by activated T lymphocytes. Plotnicky H; Touraine JL Bone Marrow Transplant; 1993 Oct; 12(4):307-14. PubMed ID: 8275029 [TBL] [Abstract][Full Text] [Related]
40. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice. Isakov N; Bach FH J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]